Dr Graham Shortland is a Consultant Paediatrician and Vice Chair of the UK National Screening Committee. His main interest is inherited metabolic disease. UK-wide roles include 6 years as chairman of the British Inherited Metabolic Disease Group, and involvement in the introduction of new UK-wide newborn blood spot screening programmes for the UK NSC. He was awarded an OBE in 2020 for services to paediatrics, patient safety and the NHS in Wales.
The UK NSC has published an update on a project called EquipoISE to make it easier to develop the evidence needed to make robust recommendations on screening newborns for rare diseases.